Investor Overview

VYNE Therapeutics™ is a biopharmaceutical company.

Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.

NASDAQ-GS: VYNE

2.15

Jun. 12, 2024 16:00:00
  • Change -0.14 (-6.1135%)
  • Volume 94,377
  • Today's Open 2.29
  • Previous Close 2.29
  • Today's High 2.36
  • Today's Low 2.11
  • 52 Week High 6.789
  • 52 Week Low 1.67